Backus H H J, Van Groeningen C J, Vos W, Dukers D F, Bloemena E, Wouters D, Pinedo H M, Peters G J
Department of Medical Oncology, VU University Medical Center, PO Box 7057, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands.
J Clin Pathol. 2002 Mar;55(3):206-11. doi: 10.1136/jcp.55.3.206.
Tumour cell growth results from a disturbance in the balance between the rate of proliferation and cell death. In this study, proteins involved in the regulation of cell cycle arrest and apoptosis were studied as possible factors responsible for uncontrolled cell growth in colorectal cancer.
The expression of proteins involved in these processes was investigated in 48 metastases from patients with colorectal cancer and compared with eight normal colon mucosa samples and 14 primary tumours. Both primary tumours and metastases were obtained from eight patients. The expression of thymidylate synthase (TS), p53, retinoblastoma protein (Rb), Fas receptor, Fas ligand, bcl-2, mcl-1, bax, and bcl-x was measured using immunohistochemistry. Proliferation was determined by Ki67 staining, whereas apoptosis was assessed by M30 immunostaining, which recognises cleaved cytokeratin 18.
In the limited number of cases in which paired comparisons were possible, the expression of TS and Ki67 was significantly higher in metastases than in the matched primary tumour samples (p = 0.014 and 0.016, respectively), whereas Rb expression was lower in metastases than in primary tumours (p = 0.024). Fas receptor expression was high in normal mucosa but absent in primary tumours and metastases, whereas the opposite was seen for p53. The expression of bax, mcl-1, and bcl-x in normal mucosa was more apical than that seen in malignant cells, where a more diffuse expression pattern was seen (p < 0.04). Apoptosis was more abundant in primary tumours than in metastases.
These results demonstrate that proliferation and apoptosis are disturbed during colorectal cancer progression, and this is accompanied by loss of Rb and Fas expression, the accumulation of p53 and TS, and changes in the expression patterns of bax, mcl-1, and bcl-xl.
肿瘤细胞生长源于增殖速率与细胞死亡之间平衡的紊乱。在本研究中,对参与细胞周期阻滞和凋亡调控的蛋白质进行了研究,以探寻其作为结直肠癌中细胞失控生长的可能因素。
在48例结直肠癌患者的转移灶中研究了参与这些过程的蛋白质表达情况,并与8例正常结肠黏膜样本和14例原发性肿瘤进行比较。原发性肿瘤和转移灶均取自8例患者。采用免疫组织化学法检测胸苷酸合成酶(TS)、p53、视网膜母细胞瘤蛋白(Rb)、Fas受体、Fas配体、bcl-2、mcl-1、bax和bcl-x的表达。通过Ki67染色确定增殖情况,而通过识别裂解细胞角蛋白18的M30免疫染色评估凋亡情况。
在有限的可进行配对比较的病例中,转移灶中TS和Ki67的表达显著高于匹配的原发性肿瘤样本(分别为p = 0.014和0.016),而转移灶中Rb的表达低于原发性肿瘤(p = 0.024)。Fas受体在正常黏膜中表达高,但在原发性肿瘤和转移灶中缺失,而p53则相反。正常黏膜中bax、mcl-1和bcl-x的表达比恶性细胞更偏向顶端,在恶性细胞中观察到更弥漫的表达模式(p < 0.04)。原发性肿瘤中的凋亡比转移灶中更丰富。
这些结果表明,在结直肠癌进展过程中增殖和凋亡受到干扰,同时伴有Rb和Fas表达缺失、p53和TS积累以及bax、mcl-1和bcl-xl表达模式的改变。